M&As this week: inviCRO, Inotek Pharmaceuticals Corporation

14th September 2017 (Last Updated September 14th, 2017 18:30)

inviCRO has completed the acquisition of UK-based translational research company Imanova.

inviCRO has completed the acquisition of UK-based translational research company Imanova.

Based in the US, the acquirer company is an imaging services and software provider, which expects the acquisition to help expand its imaging capabilities.

"Biopharmaceutical company Inotek Pharmaceuticals Corporation plans to merge with gene therapy company Rocket Pharmaceuticals."

Biopharmaceutical company Inotek Pharmaceuticals Corporation plans to merge with gene therapy company Rocket Pharmaceuticals.

The merged entity will focus on the development of gene therapies for treating rare diseases.

Both companies involved in the merger are based in the US.